Concepedia

Daniel Quirk

DQ

Statistics

Publications

13

Citations

1.5K

H-Index

13

Active since

1997

Affiliations

Brown University(Current)

Pfizer (United States)

Miriam Hospital

University of North Carolina at Chapel Hill

Roger Williams Medical Center

Daniel Quirk is an author at Brown University specializing in medicine, oncology, and malignant neoplasms.

Publications per year

1997–2021

13

Publications

13

Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia

Patrícia O. Guimarães, Daniel Quirk, Remo Holanda de Mendonça Furtado et al. · New England Journal of Medicine · 2021 · 443 citations · Full text

, , +13

A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy

Douglas K. Rex, Raj Bhandari, Taddese Desta et al. · Gastrointestinal Endoscopy · 2018 · 304 citations · Full text

, , +6

Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme

William J. Sandborn, Julián Panés, Bruce E. Sands et al. · Alimentary Pharmacology & Therapeutics · 2019 · 166 citations · Full text

, , +17

Overexpression of the HER-2/ neu Oncogene in Pancreatic Adenocarcinoma

Howard Safran, Margaret M. Steinhoff, Shamlal Mangray et al. · American Journal of Clinical Oncology · 2001 · 162 citations

, , +14

SNAI2 Modulates Colorectal Cancer 5-Fluorouracil Sensitivity through miR145 Repression

Victoria J. Findlay, Cindy Wang, Lourdes M. Nogueira et al. · Molecular Cancer Therapeutics · 2014 · 71 citations · Full text

, , +17

1–5 of 13